1. Graham-Paquin, Adda-Lee, Saini, Deepak, Sirois, Jacinthe, Bouchard, Maxime, Pastor, William A. . ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development. In Nucleic acids research, 51, 7314-7329. doi:10.1093/nar/gkad540. https://pubmed.ncbi.nlm.nih.gov/37395395/
2. Owen, Danielle J, Aguilar-Martinez, Elisa, Ji, Zongling, Li, Yaoyong, Sharrocks, Andrew D. 2023. ZMYM2 controls human transposable element transcription through distinct co-regulatory complexes. In eLife, 12, . doi:10.7554/eLife.86669. https://pubmed.ncbi.nlm.nih.gov/37934570/
3. Katoh, Masaru. 2016. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). In International journal of molecular medicine, 38, 3-15. doi:10.3892/ijmm.2016.2620. https://pubmed.ncbi.nlm.nih.gov/27245147/
4. Chang, Ya-Sian, Tu, Siang-Jyun, Chen, Yu-Chia, Fang, Hsin-Yuan, Chang, Jan-Gowth. 2021. Mutation profile of non-small cell lung cancer revealed by next generation sequencing. In Respiratory research, 22, 3. doi:10.1186/s12931-020-01608-5. https://pubmed.ncbi.nlm.nih.gov/33407425/
5. Jawhar, M, Naumann, N, Knut, M, Reiter, A, Cross, N C P. 2017. Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia. In Leukemia, 31, 2271-2273. doi:10.1038/leu.2017.240. https://pubmed.ncbi.nlm.nih.gov/28751768/